Computational Hazard Prioritization of Aerosolized E-Cigarette Flavoring Additives Using Virtual Knockout, Molecular Dynamics, and Human Genetic Follow-Up
Background/Objectives: Inhaled e-cigarette flavoring additives contact oral and respiratory epithelia, yet chemical-specific testing priorities and molecular hypotheses remain scarce. We combined chemical-screening and contextual gene-level branches to nominate priority flavorings and testable pathway hypotheses. Methods: Eight flavoring additives and carrier solvents were evaluated across 229 shared targets and 29 hubs via an 80-pair AutoDock Vina screen (exhaustiveness = 32), reference-inhibitor redocking, AlphaFold 3/Protein Data Bank checks, replicated 100 ns molecular dynamics, and ADMET/toxicity profiling with 10,000-draw weight sensitivity. Gene-level follow-up combined public transcriptomics, Mendelian randomization across eQTLGen, Genotype-Tissue Expression (GTEx), and UK Biobank cohorts, single-cell mapping, and virtual-knockout gene-set comparison. Results: The exploratory score prioritized cinnamaldehyde, menthol, and ethyl maltol above propylene glycol and glycerol across 229 shared targets and 29 hubs, retaining top three ranks in ≥99.4% of 10,000 draws (98.9% jointly) while elevating diacetyl without docking. Reference-inhibitor redocking recovered crystal poses for AKT1/3O96 (1.33–1.35 Å) and TNF/2AZ5 (0.64–1.07 Å), and three 100 ns trajectories per complex characterized Menthol-AKT1, Cinnamaldehyde-AKT1, and Menthol-TNF interactions. Genetically predicted MAPK3 expression associated with lower asthma risk in FinnGen (odds ratio = 0.90; p = 8.34 × 10−6) and GTEx (0.82–0.85), while first-order prevalence calibration of the UK Biobank linear-mixed-model estimate (β = −0.00733, p = 1.75 × 10−3; unscaled = 0.99) yielded an approximate odds ratio of 0.93. An oral endothelial MAPK3 virtual-knockout signature was enriched in e-cigarette-exposed bronchial epithelium (normalized enrichment score = 1.81; adjusted p = 9.72 × 10−4). Conclusions: This two-branch framework prioritizes three flavorings (plus diketones) for aerosol dose–response testing and nominates a MAPK3-associated hypothesis for functional validation.
Authors
- Zhongfeng Shi (ORCID: https://orcid.org/0000-0002-8105-5454)
- Qingfei Xian
- Wenni Wu (ORCID: https://orcid.org/0009-0008-7415-8333)
- Hongfei Jin
Institutions
- Guangdong Pharmaceutical University (CN)
Publication Details
- Journal
- Genes
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/genes17111472
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00